PBAC Decisions — PBS listing recommendations in plain English
The Pharmaceutical Benefits Advisory Committee recommends which drugs are listed on the PBS. This page explains in plain English what its decisions mean, and links you to the official outcomes.
A positive PBAC recommendation means a drug is one step closer to PBS listing. A negative recommendation means it was not recommended at this time — the company can reapply. PBS listing typically follows 3–6 months after a positive recommendation.
PBAC meetings
The PBAC meets several times a year, with intracycle meetings in between. Voxsanity does not currently hold PBAC meeting data, so we do not list meeting dates here — a list of dates we have no way to keep current would be worse than no list at all. The schedule is published and maintained by the Australian Government at pbs.gov.au. Our health awareness calendar says the same and points to the same place.
Drug-by-drug outcomes for each meeting (which medicines were recommended, not recommended, or deferred, and for which conditions) are published by the Australian Government. View the official plain-language summaries here:
View official PBAC outcomes on pbs.gov.au ↗
Why PBAC decisions matter
PBAC meetings are when drugs get recommended for PBS listing. If a drug for your condition is under PBAC review, the meeting outcome determines whether you can access it at an affordable, subsidised price rather than paying the full cost out of pocket. If a drug is TGA approved but not yet PBS listed, your doctor may be able to access it through the Special Access Scheme in the meantime.
Follow your condition on Voxsanity
PBAC outcomes sourced from the Australian Government Department of Health and Aged Care (health.gov.au / pbs.gov.au). Australian Government open data. This page does not constitute medical advice. Meeting schedules and outcomes may change — verify current information with the official source.